skip to main content

Predictive value of hENT1 immunohistochemistry for gemcitabine-treated pancreatic cancer is antibody dependent.

Yusuf, Dimas ; Lui, Arthur ; Abdelaziz, Zainab ; Spratlin, Jennifer L. ; Mackey, John Robert

Journal of Clinical Oncology, 05/20/2017, Vol.35(15_suppl), pp.e15746-e15746 [Peer Reviewed Journal]

Full text available

View all versions
Citations Cited by
  • Title:
    Predictive value of hENT1 immunohistochemistry for gemcitabine-treated pancreatic cancer is antibody dependent.
  • Author: Yusuf, Dimas ; Lui, Arthur ; Abdelaziz, Zainab ; Spratlin, Jennifer L. ; Mackey, John Robert
  • Is Part Of: Journal of Clinical Oncology, 05/20/2017, Vol.35(15_suppl), pp.e15746-e15746
  • Language: English
  • Identifier: ISSN: 0732-183X ; E-ISSN: 1527-7755 ; DOI: http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e15746
  • Source: CrossRef

Searching Remote Databases, Please Wait